| CYTHW Stock | | | USD 0.14 0.00 0.00% |
Cyclo Therapeutics financial indicator trend analysis is way more than just evaluating Cyclo Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cyclo Therapeutics is a good investment. Please check the relationship between Cyclo Therapeutics Non Currrent Assets Other and its Total Assets accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in rate.
For more information on how to buy Cyclo Stock please use our
How to Invest in Cyclo Therapeutics guide.
Non Currrent Assets Other vs Total Assets
Non Currrent Assets Other vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cyclo Therapeutics Non Currrent Assets Other account and
Total Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Cyclo Therapeutics' Non Currrent Assets Other and Total Assets is -0.35. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Total Assets in the same time period over historical financial statements of Cyclo Therapeutics, assuming nothing else is changed. The correlation between historical values of Cyclo Therapeutics' Non Currrent Assets Other and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Cyclo Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Currrent Assets Other i.e., Cyclo Therapeutics' Non Currrent Assets Other and Total Assets go up and down completely randomly.
Correlation Coefficient | -0.35 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Total Assets
Total assets refers to the total amount of Cyclo Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cyclo Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Cyclo Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cyclo Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in rate.
For more information on how to buy Cyclo Stock please use our
How to Invest in Cyclo Therapeutics guide.At this time, Cyclo Therapeutics'
Issuance Of Capital Stock is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to climb to 5.52 in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(0.93) in 2024.
Cyclo Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Cyclo Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cyclo Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Cyclo Stock Analysis
When running Cyclo Therapeutics' price analysis, check to
measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.